Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study on the Classification of Comprehensive Treatment Effect of Hepatocellular Carcinoma
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Summary
Through a retrospective study of patients who underwent comprehensive treatment for hepatocellular carcinoma at the Second Affiliated Hospital of Zhejiang University, we explored the risk factors related to the sensitivity of comprehensive treatment. We used the PD-L1 expression level of patients before comprehensive treatment,characteristic morphology of tertiary lymphoid structures, as well as other parameters, are used to construct a liver cancer comprehensive treatment efficacy evaluation model. Using this liver cancer comprehensive treatment efficacy evaluation model, we conducted a randomized controlled trial on whether to receive comprehensive treatment for liver cancer patients to verify the accuracy and practical value of the model.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-09-01
Completion Date
2027-05-01
Last Updated
2025-02-10
Healthy Volunteers
No
Conditions
Interventions
Immunotherapy combined with targeted therapy
Immunotherapy combined with targeted therapy
Standard treatment plan
Standard treatment plan
Locations (1)
2ndAffiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China